Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2012
09/19/2012CN102686572A Oxazoline derivatives for treatment of CNS disorders
09/19/2012CN102686570A Mesoionic pesticides
09/19/2012CN102686569A Phenoxy-substituted pyrimidines as opioid receptor modulators
09/19/2012CN102686566A New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
09/19/2012CN102686564A 吡咯烷衍生物 Pyrrolidine derivative
09/19/2012CN102686563A Substituted benzamide derivatives
09/19/2012CN102675291A Compound having triazole ring structure substituted with pyridyl group and organic electroluminescent device
09/19/2012CN102675290A Bicyclic dihydropyrazole compounds
09/19/2012CN102675289A Novel N-phenyl benzamide derivative serving as protein kinase inhibitor
09/19/2012CN102675288A 2-((2-(bi(2-picolyl) amino) ethyl) amino)-4-(3,6,6-trimethyl-4-oxyl-4,5,6,7-tetrahydroindazolyl) benzamide and preparation as well as application
09/19/2012CN102675287A Pharmaceutically acceptable salts of (E)-N-(4-((3-chloro-4-(2-pyridyl methoxy) phenyl) amino)-3-cyano-7-ethyoxyl-6-quinolyl)-3-((2R)-1-methyl pyrrolidine-2-propyl)-2-acrylamide, preparation method and application of salts in medicines
09/19/2012CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition
09/19/2012CN102675285A Method for pure water phase preparation of rabeprazole sodium
09/19/2012CN102675284A Synthesis method of delavirdine
09/19/2012CN102675283A New method for preparing bepotastine by condensation under acidic condition
09/19/2012CN102675282A Substitutive quinoline compound and application method and uses thereof
09/19/2012CN102675281A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/19/2012CN102675280A Trifluoromethyl-containing indole ketone compound, and preparation method and application thereof
09/19/2012CN102675237A New 2,4-diphenyloxazoline compounds, and synthesis method and acaricidal activity thereof
09/19/2012CN102675224A 2-substituent-7-fluorine-4-aromatic mixed base quinazoline derivant and preparation method and use thereof
09/19/2012CN102675218A Herbicidal pyrimidines
09/19/2012CN102675194A Oximes-contained amino derivative, pharmaceutical composition of oximes-contained amino derivative, preparation method of oximes-contained amino derivative and application of oximes-contained amino derivative
09/19/2012CN102675153A Antitumor action and preparation method of dicarboxylic acid monoester derivatives of hydroxamic acid
09/19/2012CN102675101A Preparation method of 2-(4-haloethyl) phenyl-2-methyl propionic ester and synthesis method of bilastine
09/19/2012CN101928277B Preparation method of 4-methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzoic acid, related intermediate and application thereof
09/19/2012CN101389352B Agent for treating or preventing digestive ulcer
09/19/2012CN101374828B Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
09/19/2012CN101245061B N-(5-amido-2-methyl phenyl)-4-(3-pyridinyl)-2-aminopyrimidine nitric oxide donating derivant, production method and uses thereof
09/18/2012US8269019 Inhibitors
09/18/2012US8269015 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2
09/18/2012US8269000 Substituted pyrimidine and triazine compounds
09/18/2012US8268999 Tri-cyclic pyrazolopyridine kinase inhibitors
09/18/2012US8268997 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
09/18/2012US8268994 Fused ring heterocycle kinase modulators
09/18/2012US8268870 Aminotetrahydroindazoloacetic acids
09/18/2012US8268869 Vinyl indazolyl compounds
09/18/2012US8268868 5-pyridinone substituted indazoles
09/18/2012US8268852 Heterocyclic inhibitors of MEK and methods of use thereof
09/18/2012US8268850 Pyrimidine derivatives and compositions as C-kit and PDGFR kinase inhibitors
09/18/2012US8268847 Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268841 Phosphonoxy quinazoline derivatives and their pharmaceutical use
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268827 Pyridazinone derivatives as PARP inhibitors
09/18/2012US8268826 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
09/18/2012US8268822 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
09/18/2012US8268815 Pyrimidine compounds and use thereof
09/18/2012US8268809 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
09/18/2012US8268751 Combination of active substances with insecticidal properties
09/18/2012CA2607907C Method for producing indole derivative having piperidine ring
09/18/2012CA2560669C Pyrrolidine-3,4-dicarboxamide derivatives
09/18/2012CA2546002C 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/18/2012CA2493326C Hydrates of a salt of (s)-pantoprazole
09/13/2012WO2012122456A2 Heavy-duty vehicle brake assembly with sealing interface
09/13/2012WO2012122340A1 Soluble guanylate cyclase activators
09/13/2012WO2012122077A1 Primary amine diazeniumdiolate heterocyclic derivatives
09/13/2012WO2012121992A1 Mst1 kinase inhibitors and methods of their use
09/13/2012WO2012121561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120415A1 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
09/13/2012WO2012120397A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012WO2012120195A1 New pyridazinone and pyridone compounds
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012119841A1 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
09/13/2012WO2012119559A1 Androgen receptor antagonists and uses thereof
09/13/2012WO2012119212A1 Imidazolidine and thiazolidine molecules with anti-t. cruzi activity
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2011100838A8 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
09/13/2012US20120232278 Insecticidal Aryl Pyrrolidines
09/13/2012US20120232270 Heteroaromatic phthalonitriles
09/13/2012US20120232265 1,2-Disubstituted Heterocyclic Compounds
09/13/2012US20120232197 Sterically hindered amine stabilizer
09/13/2012US20120232117 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
09/13/2012US20120232115 Pharmaceutical, dietary supplement, and food grade salts of anatabine
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232111 Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin
09/13/2012US20120232109 3-substituted sulfonyl piperidine derivative
09/13/2012US20120232103 Novel 5-fluorouracil derivative
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232091 Polymorphic Forms of Manidipine
09/13/2012US20120232088 Piperazinedione compounds
09/13/2012US20120232083 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232070 Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
09/13/2012US20120232068 Quinazolines as potassium ion channel inhibitors
09/13/2012US20120232064 Aspartyl protease inhibitors
09/13/2012US20120232061 Novel compounds
09/13/2012US20120232053 Quaternary ammonium compounds useful as muscarinic receptor antagonists
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232051 3-amino-pyridines as gpbar1 agonists
09/13/2012US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
09/13/2012US20120232033 Amines or amino alcohols as glyt1 inhibitors
09/13/2012US20120231459 Chemiluminescent probes for multiplex molecular quantification and uses thereof
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120230978 Compositions and methods for modulating circadian synchronization
09/13/2012US20120230949 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
09/13/2012US20120228557 Carbon-nanotube n-doping material and methods of manufacture thereof
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 1080